Silo Pharma Inc (SILO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,263 | -604 | 3,904 | 4,992 | -1,393 |
| Depreciation Amortization | N/A | N/A | 108 | 108 | 108 |
| Accounts receivable | -2 | -1 | -1 | N/A | N/A |
| Accounts payable and accrued liabilities | 41 | 65 | N/A | N/A | N/A |
| Other Working Capital | -221 | -286 | 705 | 441 | 494 |
| Other Operating Activity | 256 | 38 | -6,993 | -7,045 | -50 |
| Operating Cash Flow | $-1,189 | $-789 | $-2,278 | $-1,504 | $-841 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | 7,021 | 6,736 | N/A |
| Purchase Of Investment | 67 | N/A | N/A | N/A | N/A |
| Other Investing Activity | 20 | 20 | 172 | 107 | 70 |
| Investing Cash Flow | $87 | $20 | $7,193 | $6,843 | $70 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | 2 | 2 | 2 |
| Debt Repayment | N/A | N/A | -2 | -2 | -2 |
| Other Financing Activity | 0 | 0 | 3,794 | 3,794 | 3,794 |
| Financing Cash Flow | $N/A | $N/A | $3,794 | $3,794 | $3,794 |
| Beginning Cash Position | 9,837 | 9,837 | 1,128 | 1,128 | 1,128 |
| End Cash Position | 8,734 | 9,068 | 9,837 | 10,261 | 4,151 |
| Net Cash Flow | $-1,103 | $-769 | $8,709 | $9,133 | $3,023 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,189 | -789 | -2,278 | -1,504 | -841 |
| Free Cash Flow | -1,189 | -789 | -2,278 | -1,504 | -841 |